• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume10, Issue3

Evaluation of Malondialdehyde a, Oxidative Stress marker & Dyslipidemia in Type 2 Diabetes Mellitus patients: A Case control study

    Dr Saumya Chandra, Suman Gautam

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 3, Pages 285-291

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Diabetesis characterized by chronic hyperglycemia & disturbances of carbohydrate, lipid and protein metabolism. In subtypes of Diabetes Mellitus, type II diabetes mellitus is the most common endocrine and metabolic disorder. DM is a condition of increased oxidative stress and requires antioxidant.
Aim: To assess the association between of oxidative stress and lipid abnormalities in type 2 diabetes mellitus patients in comparison with healthy subjects.
Materials & Method: This is a case control study, conducted in Department of Biochemistry,
Era’s Lucknow Medical University, Lucknow, U.P., India between January 2022 to June 2022.  
A total of 90 cases of type II diabetes mellitus & 90 cases of healthy subjects between  the age
of 30 and 60 years were enrolled in study. Fasting blood glucose, glycated hemoglobin  (HbA1c),
 total cholesterol (TC), triglycerides (TG), high density lipid (HDL) and  malondialdehyde (MDA)
 levels were assessed.
 
Results: The mean age of type II diabetes mellitus cases were higher 55.2±10.1yr and 45±14 yrs in healthy subjects. The body mass index was higher 29.7±3.8 kg/m2 and 24.8±5.3 in healthy controls. Significant difference was observed in FBS, Hb1Ac, TC, TG, LDL, HDL along with VLDL & MDA. With TC, LDL, VLDL, FBS, HbA1c shows positive correlation between MDA and HDL.
Conclusion: Increased blood glucose levels along with dyslipidemia in patients with diabetes causes oxidative stress leading to atherosclerosis.Early detection and treatment of lipid abnormalities may be used to minimize risk for atherogenic cardiovascular disorder & cerebrovascular accident in patients with diabetes.
Keywords:
    Metabolic disorder Hb1Ac Dyslipidemia Malondialdehyde
  • PDF (395 K)
  • XML
(2023). Evaluation of Malondialdehyde a, Oxidative Stress marker & Dyslipidemia in Type 2 Diabetes Mellitus patients: A Case control study. European Journal of Molecular & Clinical Medicine, 10(3), 285-291.
Dr Saumya Chandra, Suman Gautam. "Evaluation of Malondialdehyde a, Oxidative Stress marker & Dyslipidemia in Type 2 Diabetes Mellitus patients: A Case control study". European Journal of Molecular & Clinical Medicine, 10, 3, 2023, 285-291.
(2023). 'Evaluation of Malondialdehyde a, Oxidative Stress marker & Dyslipidemia in Type 2 Diabetes Mellitus patients: A Case control study', European Journal of Molecular & Clinical Medicine, 10(3), pp. 285-291.
Evaluation of Malondialdehyde a, Oxidative Stress marker & Dyslipidemia in Type 2 Diabetes Mellitus patients: A Case control study. European Journal of Molecular & Clinical Medicine, 2023; 10(3): 285-291.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 36
  • PDF Download: 57
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus